Efficacy and Safety of Everolimus in Korean Patients with Metastatic Renal Cell Carcinoma Following Treatment Failure with a Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor

PURPOSE: The purpose of this study is to assess the efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma (mRCC) for whom initial treatment with a vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) has failed. MATERIALS AND METHODS:...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Park, Kwonoh, Lee, Jae-Lyun, Ahn, Jin-Hee, Lee, Kyoo Hyung, Jeong, In-Gab, Song, Cheryn, Hong, Bumsik, Hong, Jun Hyuk, Ahn, Hanjong
Format: Artigo
Sprache:Inglês
Veröffentlicht: Korean Cancer Association 2014
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4206076/
https://ncbi.nlm.nih.gov/pubmed/25036572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2013.154
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge